tiprankstipranks
Advertisement
Advertisement

MESO Stock Latest News

Mesoblast Grants New Director Options Following 2025 AGM Approvals
Company AnnouncementsMesoblast Grants New Director Options Following 2025 AGM Approvals
7d ago
6K
MESO
Mesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026
PremiumCompany Announcements
Mesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026
17d ago
6K
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
18d ago
KDK
MPT
Mesoblast Earnings Call: Ryoncil Momentum Meets Rising Costs
PremiumCompany Announcements
Mesoblast Earnings Call: Ryoncil Momentum Meets Rising Costs
1M ago
MESO
Mesoblast Sets Webcast to Present Half-Year 2025 Results and Corporate Update
PremiumCompany Announcements
Mesoblast Sets Webcast to Present Half-Year 2025 Results and Corporate Update
1M ago
6K
MESO
Mesoblast Touts Ryoncil Survival Data, Prepares Adult SR-aGvHD Pivotal Trial
PremiumCompany AnnouncementsMesoblast Touts Ryoncil Survival Data, Prepares Adult SR-aGvHD Pivotal Trial
2M ago
6K
MESO
Mesoblast Lifts Ryoncil Revenues, Secures Cheaper Credit and Advances Late-Stage Cell Therapy Pipeline
Premium
Company Announcements
Mesoblast Lifts Ryoncil Revenues, Secures Cheaper Credit and Advances Late-Stage Cell Therapy Pipeline
2M ago
6K
MESO
Mesoblast Reports 84% Survival in Early Real‑World Use of Ryoncil for Pediatric SR‑aGvHD
Premium
Company Announcements
Mesoblast Reports 84% Survival in Early Real‑World Use of Ryoncil for Pediatric SR‑aGvHD
2M ago
6K
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
GDS
MMM
Mesoblast Wins FDA Backing on Pain and Opioid-Reduction Data for Rexlemestrocel-L in Chronic Low Back Pain
PremiumCompany Announcements
Mesoblast Wins FDA Backing on Pain and Opioid-Reduction Data for Rexlemestrocel-L in Chronic Low Back Pain
2M ago
6K
MESO
Mesoblast received FDA feedback on potential BLA for rexlemestrocel-L
PremiumThe Fly
Mesoblast received FDA feedback on potential BLA for rexlemestrocel-L
2M ago
MESO
Mesoblast Trims Option Overhang After Late-2025 Lapse of 1.45 Million Unquoted Options
PremiumCompany Announcements
Mesoblast Trims Option Overhang After Late-2025 Lapse of 1.45 Million Unquoted Options
2M ago
6K
MESO
Mesoblast Expands Share Capital After Exercise of 6.9 Million Options
PremiumCompany AnnouncementsMesoblast Expands Share Capital After Exercise of 6.9 Million Options
2M ago
6K
MESO
Mesoblast Lapses 3 Million Unquoted Warrants, Slightly Simplifying Capital Structure
Premium
Company Announcements
Mesoblast Lapses 3 Million Unquoted Warrants, Slightly Simplifying Capital Structure
3M ago
6K
MESO
Mesoblast chair Jane Bell to transition out of role, Philip Facchina to succeed
Premium
The Fly
Mesoblast chair Jane Bell to transition out of role, Philip Facchina to succeed
3M ago
MESO
Mesoblast Issues 5 Million Unquoted Warrants as Fee for US$50 Million Convertible Note Facility
PremiumCompany Announcements
Mesoblast Issues 5 Million Unquoted Warrants as Fee for US$50 Million Convertible Note Facility
3M ago
6K
MESO
Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025
PremiumCompany Announcements
Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025
4M ago
6K
MESO
Mesoblast Achieves FDA Approval for Ryoncil®
PremiumCompany Announcements
Mesoblast Achieves FDA Approval for Ryoncil®
4M ago
6K
MESO
Mesoblast upgraded to Buy at Jefferies as Ryoncil roll out continues
PremiumThe Fly
Mesoblast upgraded to Buy at Jefferies as Ryoncil roll out continues
4M ago
MESO
Mesoblast upgraded to Buy from Hold at Jefferies
PremiumThe FlyMesoblast upgraded to Buy from Hold at Jefferies
4M ago
MESO
Mesoblast to Launch Pivotal Ryoncil® Trial for Severe aGvHD in Adults
Premium
Company Announcements
Mesoblast to Launch Pivotal Ryoncil® Trial for Severe aGvHD in Adults
4M ago
6K
MESO
Mesoblast collaborating with BMT CTN on trial of Ryoncil in acute GvHD
Premium
The Fly
Mesoblast collaborating with BMT CTN on trial of Ryoncil in acute GvHD
4M ago
MESO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >